ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0036499;PERK-mediated unfolded protein response;6.0;1.0;0.8231203125901445;9.628524252492122;80.02054155744251;7.292166977892469;0.0026782155121157316;0.6960420709600095;[EIF2AK3]
GO:0007131;reciprocal meiotic recombination;9.0;1.0;0.896240625180289;9.628524252492122;175.07189671554147;6.343086423195323;0.005859498828591432;0.7206263598461826;[RAD51C, MSH3]
GO:0036492;eiF2alpha phosphorylation in response to endoplasmic reticulum stress;11.0;1.0;0.9324289523296623;9.628524252492122;1396.0405641862526;9.083926447120524;0.04672422132837557;0.8969813732811862;[EIF2AK3]
GO:0030150;protein import into mitochondrial matrix;10.0;1.0;0.9152410118609203;9.628524252492122;478.64673420754235;6.781341354126479;0.01601987543983258;0.7620391240755716;[TIMM44]
GO:1903883;positive regulation of interleukin-17-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;305.68887294206377;9.777073627680469;0.01023113147524637;0.875;[TRIM32]
GO:0034198;cellular response to amino acid starvation;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;115.90251486529202;5.970411137910149;0.003879152867050031;0.6562464685024372;[BECN1, CDKN1A, SEH1L, EIF2AK3]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[DDB1, AQR, COPS5, POLR2B, EP300, POLR2G, GTF2H4]
GO:0007014;actin ubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;339.2636871499833;9.777073627680469;0.011354850291414396;0.9152410118609203;[TRIM32]
GO:0042256;mature ribosome assembly;8.0;1.0;0.875;9.628524252492122;107.99803396519857;7.8311634786251565;0.003614597004894861;0.7754860644832351;[C1QBP]
GO:1903886;positive regulation of chemokine (C-C motif) ligand 20 production;7.0;1.0;0.8509193652572005;9.628524252492122;88.62106486279957;9.777073627680469;0.0029660672871775788;0.8509193652572005;[TRIM32]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[MTPN, UBE2I, BUD31, SPHK1, ITGB2, CIB1, NLRC4, TMEM173, PPRC1, LRP8, STK3, COPS5, EP300, TRIM14, NLRP3, TRIM32, ARHGEF5]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[MTPN, SPHK1, ITGB2, TRIM14, NLRP3, CIB1, NLRC4, TRIM32]
GO:0034629;cellular protein-containing complex localization;5.0;0.7043150770688792;0.6423985503953599;8.616923340813642;38.207100950210915;6.599019797332524;0.0012787572846451128;0.6277151911823093;[SEH1L, EXOC1]
GO:0000184;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;10.0;0.8933024483968273;0.861892236059334;9.57851383191746;717.2549128915896;4.989581884898423;0.0240058764469685;0.6704084614939124;[UPF2, UPF1, RPS9, RPL3, RPL23A, CASC3, SMG5, DCP2, RPL19]
GO:0019240;citrulline biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;472.0159725266005;8.390779266560578;0.015797949813669537;0.8253454670833372;[CAD]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[NCF1, MAML1, GFI1, ARID4A, RORA, IKZF2, ELK1, YY1, ZXDC, DPF2, TRIM24, EP300, SOX8, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, ILF3, SFRP1, KARS, IL23A, RFX4, HOXB4, MAX, RLF, SUPT6H, HLTF, DVL3, SCAP, NLRP3, TFAP2A, DR1, CREBBP, PBX3, EIF2AK3, ERLIN2, FLI1, SETX, CDK9, NFKBIA, TFCP2, COPS5, SP1, SP3, MAFF, BCL3, NFE2L3, CDKN1C, CIITA, ONECUT2, ELL, DDX41, HOXC13, AATF, FLCN, NIPBL, LBH, NUP62, ZNF485, TBP, KLF13, PEG3, DTX3L, NCOA6, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, CREB3, GAL, TFDP2, MTF2, TFEC, HDAC3, ZNF350, HDAC1, WBP2, ARNTL, SERTAD3, RXRA, TP53INP2, TP53INP1, GPBP1L1, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, GRHL1, USF2, CD4, NFIB, NFIC, CAMK4, TAF7, CAMK1]
GO:0006958;complement activation, classical pathway;8.0;1.0;0.875;9.628524252492122;171.02669507306572;4.7081694254602375;0.005724109570062889;0.6157760033703056;[C1QBP, C1QC, C2]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[NFKBIA, BCL3, TNPO2, KPNB1, IPO4, ARNTL]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[C1QBP, PDCD1LG2]
GO:0001829;trophectodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;7.212124270218933;7.050676185779127E-4;0.6188283705770736;[SP3, BYSL]
GO:0006296;nucleotide-excision repair, DNA incision, 5'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;6.166155715036245;0.0038535917232456105;0.6903374900225189;[DDB1, GTF2H4]
GO:0006293;nucleotide-excision repair, preincision complex stabilization;7.0;1.0;0.8509193652572005;9.628524252492122;108.6814430544141;6.7325511899570465;0.003637470092082656;0.6952223462072524;[DDB1, GTF2H4]
GO:0007141;male meiosis I;8.0;1.0;0.875;9.628524252492122;140.0657740590801;6.641579411751319;0.004687875406744682;0.7146506799819907;[RAD51C]
GO:0006294;nucleotide-excision repair, preincision complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;65.90281547005735;6.409777797693995;0.002205707925099542;0.6787156999164222;[DDB1, GTF2H4]
GO:0048009;insulin-like growth factor receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;7.138016298065211;0.0010376185600805164;0.7400384854347593;[EIF2AK3]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[ALS2, VDAC3, MBP, NPTX1, SNCB, SPG11, KCNK3, NTSR1, PAFAH1B1, GLS]
GO:1900026;positive regulation of substrate adhesion-dependent cell spreading;8.0;1.0;0.875;9.628524252492122;350.51777089970517;6.280566066213989;0.011731514346499779;0.6961884407023742;[FGA, ARPC2, C1QBP, FGG, CIB1, UNC13D, LIMS1]
GO:0006177;GMP biosynthetic process;11.0;0.9326813400603323;0.8987696223598284;9.61370916670698;9653.00334287648;8.16763571524637;0.323077334747084;0.8501222226412654;[IMPDH2]
GO:0044205;'de novo' UMP biosynthetic process;12.0;1.0;0.9481203125901445;9.628524252492122;8937.403968818055;8.67846133901236;0.2991268676949733;0.8919372290569614;[CAD]
GO:0042148;strand invasion;7.0;0.8436909121759173;0.7727648213451592;9.456673995565463;149.0421272461911;7.8311634786251565;0.0049883058697239;0.7514054297404357;[RAD51C]
GO:0006612;protein targeting to membrane;10.0;0.811012628672052;0.8207473261969463;9.414950152194063;149.73401455281405;4.753193106834193;0.0050114627152184205;0.6583195283905053;[PEX16, TRAM1, RPS9, PEX19, RPL3, NCF1, SSR2, ZDHHC23, ZDHHC24, RPL23A, RAB8B, RPL19]
GO:0042149;cellular response to glucose starvation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;115.90251486529202;6.063501560976162;0.003879152867050031;0.6610071170671804;[BECN1, TBL2, EIF2AK3, CPEB4]
GO:0006610;ribosomal protein import into nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;278.22868408041535;7.697632086000634;0.009312063666612497;0.8088982747154926;[TNPO2, KPNB1, IPO4]
GO:0006607;NLS-bearing protein import into nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;278.22868408041535;6.481236761676141;0.009312063666612497;0.7466917612613706;[TNPO2, KPNB1, IPO4]
GO:0071364;cellular response to epidermal growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.088194173566533;0.003262744749111514;0.63447084575632;[VIL1, BECN1, ERRFI1, CAD]
GO:0031100;animal organ regeneration;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;28.087648497102798;5.420364800990877;9.400683179555208E-4;0.5271977079954144;[UPF2, NFKBIA, CDKN1A, CAD, LCP1, RPL19, EZH2]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[SETX, BECN1, NCF1, PXMP2, ECT2, EZH2]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[IGFBP5, C1QBP, THBS1, STK3]
GO:0032434;regulation of proteasomal ubiquitin-dependent protein catabolic process;10.0;0.7307253602413294;0.7806036919815851;9.240758721483358;451.96383804573134;4.964889272308052;0.015126822918344251;0.6691456801377169;[ZFAND2A, GLMN, CLEC16A, UBQLN1, RAD23A, SIRT2]
GO:0051414;response to cortisol;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;108.88143258541243;8.16763571524637;0.003644163561706277;0.7926932703116032;[CAD]
GO:0006383;transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.499312521012115;583.8786478812184;6.113511981550823;0.01954189288791682;0.7278862989048107;[TBP, ELL, POLR3C, POLR3E]
GO:0043928;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;11.0;0.9326813400603323;0.8987696223598284;9.60383163990175;718.8643508040237;6.280566066213989;0.024059742885497587;0.7536173930320365;[HBS1L, CNOT6, CNOT8, LSM5, DCP2]
GO:0007597;blood coagulation, intrinsic pathway;6.0;1.0;0.8231203125901445;9.628524252492122;55.78978942234946;6.943860283624253;0.0018672340444153065;0.6782296504172152;[C1QBP, A2M]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, MAP3K3, CD4, UBE2I, NUP62, ZDHHC13, ECT2, TRIM32]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[TMEM30A, FOXG1, TRAK1, LRP8, CYB5D2, RAB21, SETX, FES, RUFY3, DVL3, CAMK1, ADNP, ECT2, SCARF1, TRIM32, MARK2, PAFAH1B1, EZH2]
GO:0045787;positive regulation of cell cycle;5.0;0.5265193887476639;0.5535007062347522;7.230628979693751;42.184038669436575;3.8238302933926853;0.0014118618110960173;0.4857918708913159;[ANKRD17, BECN1, FEN1, BTG2, CDKN1A, FOXG1, CCNF, ANAPC11, NIPBL, SPAST, TPR, FNTB, NUP62, CASP2, EP300, ECT2, E2F7, E2F8, UBE2B, SPHK1, FLT3LG, CNOT10, RAD23A, NDC80, SIRT2, CDK9, NSFL1C, CNOT6, RAD51C, ESPL1, TFDP2, FAP, CNOT1, PKP4, ANAPC5, CNOT8, TRIM32, PAFAH1B1, CCNJL, MAD2L1]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[OXTR, CAD, ATP7A, USF2]
GO:0000398;mRNA splicing, via spliceosome;11.0;0.8259837884571596;0.845420846558242;9.4949928598676;356.66873027722005;4.19357731889877;0.011937381421361158;0.6468886914394342;[SF3B5, AQR, SF3B2, GPKOW, BUD31, CPSF2, DDX42, DDX41, CASC3, USP39, LSM5, SRRM1, EFTUD2, PABPN1, PCF11, U2AF2, POLR2B, SNRPG, SNRPB2, POLR2G, SLU7, SMNDC1, RBM5]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[FGA, SERPINA3, ITGB3, FGG, LAMP2, CD9, RAB27B, FAM3C, CALM1, ALDOA, A2M, THBS1]
GO:0006814;sodium ion transport;7.0;0.811012628672052;0.7564256795932265;9.310070521373587;34.16983994150393;4.629579150867016;0.001143633791982704;0.5876762583299873;[SLC5A6, SLC23A2, SLC9A6, COMMD3, PKD2L1]
GO:0048147;negative regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.87354995152188;6.409777797693995;0.0021377902344145586;0.6509166472493662;[SFRP1, TP53INP1, TRIM32]
GO:0048025;negative regulation of mRNA splicing, via spliceosome;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;1181.5966005326304;6.781341354126479;0.03954697485192635;0.7620391240755716;[U2AF2, C1QBP]
GO:0032543;mitochondrial translation;8.0;1.0;0.875;9.628524252492122;403.65714686199146;6.193554689224359;0.013510041437624024;0.6917386748366816;[NDUFA7, MRPS24, MRPS18A]
GO:0015887;pantothenate transmembrane transport;9.0;1.0;0.896240625180289;9.628524252492122;278.06427582741907;9.777073627680469;0.009306561070342532;0.896240625180289;[SLC5A6]
GO:0000724;double-strand break repair via homologous recombination;9.0;0.8653626801206646;0.8289219652406215;9.515195567185119;520.6240308586224;5.299736813202263;0.01742481778162994;0.6672694122704188;[YY1, RAD51AP1, NIPBL, FEN1, WDR48, RAD51C, FBXO18, GINS4]
GO:0000722;telomere maintenance via recombination;9.0;0.9326813400603323;0.8625812952104552;9.593432932680852;337.7230221555657;7.212124270218933;0.011303285620559713;0.7650689957573628;[RAD51C]
GO:0006397;mRNA processing;8.0;0.7140352122741334;0.7320176061370667;9.165900730544008;234.3529203123214;3.6745150330669007;0.00784358133891816;0.5629148696734654;[TRUB2, SF3B5, SF3B2, AHCYL1, DDX42, DDX41, CASC3, USP39, SUPT6H, EFTUD2, ALKBH5, PABPN1, PCF11, U2AF2, POLR2B, C1QBP, ARL6IP4, SNRPB2, POLR2G, ZNF326, SMNDC1, RBM5, AQR, CPSF6, GPKOW, WTAP, BUD31, CPSF2, SSU72, THOC2, LSM5, GTF2H4, SRRM1, ERN1, PAN3, SON, FASTKD5, SNRPG, SLU7]
GO:0046651;lymphocyte proliferation;5.0;0.6873818243518346;0.6339319240368375;8.734706376470026;28.263571572696247;5.500407508664414;9.459563049751445E-4;0.571532107649126;[CD151, IL23A, DOCK8, IMPDH2, DOCK2]
GO:0000050;urea cycle;6.0;1.0;0.8231203125901445;9.628524252492122;229.46365912673008;7.292166977892469;0.007679942167085809;0.6960420709600095;[CAD]
GO:0051315;attachment of mitotic spindle microtubules to kinetochore;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;27.921945865447032;7.379178354882098;9.345223999966889E-4;0.6273715242355574;[SEH1L, NUF2, NDC80]
GO:0032897;negative regulation of viral transcription;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;62.48948681665221;6.641579411751319;0.0020914668868664225;0.6905700452391912;[HDAC1, TRIM14, TRIM32]
GO:0008380;RNA splicing;8.0;0.7248374789738407;0.7374187394869203;9.182237149863703;117.47952805794706;3.8501476017100584;0.003931934079388465;0.5718967274016261;[SF3B5, SF3B2, DDX42, DDX41, CASC3, USP39, SUPT6H, EFTUD2, PABPN1, PCF11, U2AF2, POLR2B, C1QBP, ARL6IP4, SNRPB2, POLR2G, ZNF326, SMNDC1, RBM5, AQR, GPKOW, WTAP, BUD31, CPSF2, THOC2, LSM5, SRRM1, ERN1, SON, SNRPG, SLU7]
GO:1902511;negative regulation of apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;903.8812513126919;9.777073627680469;0.030252092041122634;0.896240625180289;[DFFA]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[VASP, RXRA, ALDH5A1, IMPDH2, ATPIF1, ALDOA, GLS]
GO:0006999;nuclear pore organization;5.0;0.8933024483968273;0.736892236059334;9.4949928598676;38.430292282043744;7.069023426578259;0.0012862272976623997;0.6517511986393402;[AHCTF1, SEH1L, TPR, NUP153]
GO:0070126;mitochondrial translational termination;7.0;1.0;0.8509193652572005;9.628524252492122;40.68669918132259;5.277263957350204;0.0013617472059468932;0.6207988894539612;[MRPL40, MRPS24, MRPS36, MRPS22, MRPS18A, MRPL17]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFNAR2, BECN1, APOBEC3F, DTX3L, APOBEC3H, DDX41, TMEM173, LYST, UNC13D, ITCH, ILF3, POLR3C, IL23A, POLR3E, NLRP3, SERINC3, EXOC1]
GO:0070125;mitochondrial translational elongation;7.0;1.0;0.8509193652572005;9.628524252492122;106.95016378538953;5.299736813202263;0.0035795257329985885;0.6219481523473303;[MRPL40, MRPS24, MRPS36, MRPS22, MRPS18A, MRPL17]
GO:0033574;response to testosterone;5.0;0.9326813400603323;0.7565816818910864;9.533214072687796;91.03892825708995;6.063501560976162;0.003046990999048697;0.6003287636709002;[XRN1, TBXA2R, CAD, ELK1, THBS1]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[PER2, GNL3L, DTX3L, U2AF2, GLMN, FBXO5, SENP2, MAD2L1]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[MCTP1, CCL20, SPHK1, RCAN3, EIF2AK3, DEFB1, NMUR1, CALM1, CALM2, CCR2]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[EIF2AK3, ARNT, RORA]
GO:1904263;positive regulation of TORC1 signaling;9.0;1.0;0.896240625180289;9.628524252492122;286.95354203151174;7.57984905034425;0.009604076810373322;0.7838744581139225;[SEH1L, CLEC16A]
GO:0007066;female meiosis sister chromatid cohesion;7.0;1.0;0.8509193652572005;9.628524252492122;102.551956282821;9.777073627680469;0.003432321686017388;0.8509193652572005;[RAD51C]
GO:0045732;positive regulation of protein catabolic process;7.0;0.7043150770688792;0.7030769037916401;9.033817144745429;231.0521549826792;4.39257856489138;0.0077331076938309705;0.5755560373415389;[CSNK2A1, ZFAND2A, EDEM1, ATPIF1, RAD23A, SIRT2, DDB1, ITCH, VPS11, UBQLN1, STX5, TRIM32, DACT1]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PDXK, SIGLEC9, CLEC12A, ITGB2, IQGAP2, HK3, PSMD2, PSMB1, LAMP2, NCKAP1L, GUSB, SNAP29, SERPINB1, TMEM30A, FCER1G, HSPA6, PLAUR, COMMD3, RNASE3, TMEM173, LILRB3, UNC13D, SERPINB6, IMPDH2, RAB18, PTX3, MNDA, DOCK2, ALDOA, KPNB1]
GO:0006412;translation;7.0;0.8653626801206646;0.7836007053175329;9.510741216835738;402.5585345733233;4.39257856489138;0.01347327187300917;0.5755560373415389;[HBS1L, RPS9, NDUFA7, RPL3, MRPS24, MRPS36, MRPS18A, RRBP1, RPL23A, RPL3L, COPS5, RPL36AL, RPL19, CPEB4]
GO:0006406;mRNA export from nucleus;9.0;0.8933024483968273;0.8428918493787028;9.523163736834295;121.36021434248079;5.132682728539097;0.004061817156940898;0.658726258611935;[UPF2, UPF1, SEH1L, CPSF2, NUP153, THOC2, CASC3, SMG5, SRRM1, ALKBH5, NXF3, PABPN1, U2AF2, TPR, NUP62, NUP43, SLU7]
GO:0006526;arginine biosynthetic process;10.0;0.9326813400603323;0.8815816818910864;9.590783924509275;561.9604623136129;7.8311634786251565;0.018808310942055415;0.8157270763441555;[CAD]
GO:0006768;biotin metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.541512875502493;225.22419288055787;7.8311634786251565;0.007538051047098339;0.7514054297404357;[PCCA]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[CMTM7, ERRFI1, UBE2I, NCF1, CCL20, BUD31, FLT3LG, GAL, IL23A, NPPA, FAM3C, CHMP6, KCNK3]
GO:0070911;global genome nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;6.518977089658987;0.006172937954381027;0.7296214167088868;[DDB1, GTF2H4]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[BBS2, RAB3B, SYS1, FCER1G, SLMAP, ZDHHC23, TMED2, ABCA12, VAMP5, RAB8B]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[HIST1H2BO, HIST1H2BJ, RNF38, CCNF, NEDD8, DTX2, NLRC4, ANAPC11, UBE2L3, VCPIP1, TRIM9, NPEPPS, HERC1, CDC26, HLTF, TRIM24, TRIM69, RFFL, SKP2, C18orf25, UBE2I, UBE2B, FBXO18, KLHL25, DTX3L, SYVN1, ZFP91, FBXL15, LNPEP, FBXL16, DDB1, ITCH, KCTD10, UBE2T, TSPAN17, FBXL3, ANAPC5, TRIM32, HIST1H2BC]
GO:0046716;muscle cell cellular homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.94563669038233;6.781341354126479;0.0010691917108206317;0.6370391240755715;[LAMP2, ALDOA, TRIM32]
GO:0006183;GTP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;9648.749331526727;7.379178354882098;0.32293495681556944;0.8098004765652196;[IMPDH2]
GO:0045862;positive regulation of proteolysis;8.0;0.6144040707577935;0.6822020353788967;8.732436227935485;336.2761553273835;3.9393431805145296;0.011254860289916062;0.5764581934497054;[WDR48, DIABLO, ZFAND2A, EDEM1, ATPIF1, EIF2AK3, RAD23A, NLRC4, HSPE1, SIRT2, BBC3, NLRP12, KARS, UBQLN1, PSME2, NLRP3, MBP, BID, TRIM32]
GO:0006986;response to unfolded protein;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;23.958124258549983;5.75172193694532;8.018568580216882E-4;0.5843843391987277;[HERPUD2, HSPA6, HSPB3, HSPE1, THBS1]
GO:0006983;ER overload response;6.0;0.8653626801206646;0.7558016526504768;9.434368238051164;81.5596405220072;7.379178354882098;0.002729727769360572;0.7004918368257019;[EIF2AK3]
GO:0006614;SRP-dependent cotranslational protein targeting to membrane;12.0;1.0;0.9481203125901445;9.628524252492122;336.65241395888097;5.288437257948329;0.011267453327701498;0.718571239899105;[RPS9, RPL3, RPL23A, RPL19]
GO:0071353;cellular response to interleukin-4;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;6.599019797332524;0.0027327542132076126;0.6605944919115335;[RPL3, IMPDH2, MCM2]
GO:0001967;suckling behavior;3.0;1.0;0.6981203125901445;9.628524252492122;23.343114208171034;7.212124270218933;7.812730251086156E-4;0.5669486831672182;[OXTR, DERL2, GLS]
GO:0016310;phosphorylation;5.0;0.5310727365277519;0.5557773801247963;6.876988939450173;24.405590426795786;2.7321685105510984;8.168331479794688E-4;0.42996423654933263;[CIITA, OXTR, MAST3, MAML1, DGKA, IL5RA, HK3, ZMYM2, RPS6KA2, TRIM24, TPI1, CSNK2A1, KSR1, SPHK2, SPHK1, CAD, BPGM, GFRA2, SPTB, COASY, ERN1, BCR, ILF3, KARS, PDIK1L, FASTKD5, EPHA1, ALDOA, PDXK, ATP5I, COX5B, ATP5O, RASGRP4, ATP5L, STK3, NUAK1, PABPN1, STK38, MKNK2, STK38L, NCAM1, MBP, CYC1, MARK2, MAP3K3, EIF2AK3, DOLK, ERLIN2, CLK4, GTF2H4, CLK3, SETX, CLK1, CDK9, GNPTG, SNRK, UCK2, PAN3, PTPRA, FES, CAMK4, CCM2, CAMK1, CALM1]
GO:0039536;negative regulation of RIG-I signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;832.8511462772416;7.697632086000634;0.027874778348530416;0.7898978880348613;[C1QBP]
GO:0070816;phosphorylation of RNA polymerase II C-terminal domain;11.0;0.811012628672052;0.8379352666656883;9.52844079393514;433.3999751397635;7.8311634786251565;0.014505507133273452;0.8329150168128974;[CDK9, GTF2H4]
GO:0039534;negative regulation of MDA-5 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;832.8511462772416;8.390779266560578;0.027874778348530416;0.8253454670833372;[C1QBP]
GO:0070936;protein K48-linked ubiquitination;11.0;1.0;0.9324289523296623;9.628524252492122;157.60047254366168;5.8650506222523235;0.00527474598481953;0.7323679139043926;[ITCH, UBE2B, DTX3L, UBE2T, SYVN1, RFFL, TRIM32]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[HSPA6, HSPE1]
GO:0034080;CENP-A containing nucleosome assembly;9.0;1.0;0.896240625180289;9.628524252492122;242.74046782674554;6.343086423195323;0.00812430500592325;0.7206263598461826;[OIP5, CENPP, ITGB3BP]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[USP36, USP32, RNF38, USP12, CCNF, DERL2, NEDD8, PSMB10, PSMA7, ANAPC11, ARNTL, UBE2L3, PSMD8, TRIM9, TP53INP2, PSMD2, CDC26, PSMB1, UBQLN1, USP51, RFFL, SKP2, C18orf25, USP46, UBE2I, LRRC29, UBE2B, FBXO18, KLHL25, DTX3L, EDEM1, SYVN1, FBXL15, RAD23A, ERLIN2, FBXL16, SIRT2, DDB1, KBTBD4, NSFL1C, ITCH, PSMA1, KCTD10, FBXL3, ANAPC5, MAN1B1, TRIM32, MAD2L1]
GO:0006626;protein targeting to mitochondrion;10.0;1.0;0.9152410118609203;9.628524252492122;196.80778803422263;6.250713103064308;0.006586979549995513;0.734902770639515;[TIMM44, BID]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD4, GLMN]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[ANKRD17, COLEC12, HIST1H2BJ, NCF1, CFH, DEFB1, NLRC4, LILRA2, LYST, C2, PPP6C, PRDX1, C1QBP, SLAMF7, NLRP3, FGA, APOBEC3F, FCER1G, DTX3L, APOBEC3H, WRNIP1, RNASE3, TMEM173, SIRT2, ITCH, POLR3C, IL23A, FES, POLR3E, TRIM14, PTX3, SERINC3, TRIM32, CD244, C1QC, HIST1H2BC]
GO:0070131;positive regulation of mitochondrial translation;9.0;0.8653626801206646;0.8289219652406215;9.543966864464059;1252.1923355105296;7.379178354882098;0.0419097505696;0.7736121494158466;[C1QBP]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[ITCH, GLMN, PDCD1LG2]
GO:0031000;response to caffeine;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;108.60320465904744;7.069023426578259;0.003634851523399718;0.6846304993685643;[CAD]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[C1QBP, THBS1]
GO:0014065;phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;26.42836680105094;6.343086423195323;8.845336528452411E-4;0.6993857346658935;[C1QBP, SIRT2]
GO:0002087;regulation of respiratory gaseous exchange by neurological system process;6.0;1.0;0.8231203125901445;9.628524252492122;40.361908422019745;7.212124270218933;0.0013508767515257331;0.6919486831672181;[PBX3, GLS]
GO:0006446;regulation of translational initiation;8.0;0.622025257344104;0.686012628672052;8.744321835169467;215.8173094633638;5.433268205826786;0.007223211124770292;0.6528575887187926;[EIF5B, RXRA, KLHL25, TPR, EIF2AK3, POLR2G]
GO:0000462;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);11.0;1.0;0.9324289523296623;9.628524252492122;360.17083382419077;6.221725566191056;0.0120545936753897;0.7506082871245006;[BYSL]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[MTPN, SFRP1, CSNK2A1, SPHK1, RUFY3, H3F3A, DERL2, CIB1, ADNP, TRIM32, PAFAH1B1]
GO:0000460;maturation of 5.8S rRNA;10.0;0.8933024483968273;0.861892236059334;9.533214072687796;358.78453946307087;6.832634648514029;0.012008195650706942;0.7646622655359331;[LAS1L]
GO:2000510;positive regulation of dendritic cell chemotaxis;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;509.141903474748;7.697632086000634;0.01704052131133542;0.8088982747154926;[C1QBP]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[NLRP12, IL4R, KARS, NLRP7, GLMN, NLRP3, MBP, CD244]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BJ, NLRP3, DEFB1, RNASE3, HIST1H2BC]
GO:0045815;positive regulation of gene expression, epigenetic;7.0;0.7763722522362496;0.7391054913753253;9.081980546124052;79.85422672196849;5.8650506222523235;0.0026726491042460506;0.6508583268319309;[TBP, WBP2, ATAD2, TAF1A, EP300, POLR1E]
GO:0014075;response to amine;5.0;0.7980440201809971;0.6892630219514189;9.223059144383958;29.79647000066773;6.139487467954083;9.972610358403309E-4;0.6042146864874571;[OXTR, ITGA2, CAD]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[COLEC12, VASP, PDCD6IP, KCND1, FCER1G, ATPIF1, EIF2AK3, PKD2L1, NLRC4, CLYBL, GLS, MARCKS, SPAST, RXRA, ALDH5A1, KCTD10, IMPDH2, KCTD14, ECT2, ALDOA, BID]
GO:0006336;DNA replication-independent nucleosome assembly;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;163.41517932017535;6.088194173566533;0.005469358987733092;0.6863505331661754;[H3F3A, UBN1, OIP5, CENPP, IPO4, ITGB3BP]
GO:0006335;DNA replication-dependent nucleosome assembly;8.0;1.0;0.875;9.628524252492122;163.41517932017535;7.474488534686424;0.005469358987733092;0.7572456912631272;[CHAF1A, IPO4]
GO:0006207;'de novo' pyrimidine nucleobase biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;824.8871332178428;7.9853141584524145;0.02760822999857876;0.8046099625986299;[CAD]
GO:0000470;maturation of LSU-rRNA;10.0;0.8436909121759173;0.837086467948879;9.446202695698167;358.78453946307087;6.558197802812269;0.012008195650706942;0.7506275524841266;[LAS1L]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[SEMA6B, MTPN, CDKN1A, CSNK2A1, IGFBP5, SPHK1, H3F3A, DERL2, CIB1, TMEM97, FBLN5, RAB21, OLFM1, FLCN, ITCH, KIAA1109, SERTAD3, SFRP1, GAL, RUFY3, NPPA, ADNP, TRIM32, PAFAH1B1]
GO:0014047;glutamate secretion;10.0;0.9326813400603323;0.8815816818910864;9.574457031221845;161.52301102016722;6.8867018697843045;0.005406029817572731;0.7674272657460779;[GLS]
GO:1903265;positive regulation of tumor necrosis factor-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;305.68887294206377;7.57984905034425;0.01023113147524637;0.7626338329336335;[TRIM32]
GO:0006541;glutamine metabolic process;9.0;0.7671156992804218;0.7797984748205;9.245532000236016;86.07328877610979;6.641579411751319;0.002880795514405686;0.7358913051622797;[ALDH5A1, CAD, GLS]
GO:0006421;asparaginyl-tRNA aminoacylation;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;205.4345073903719;8.67846133901236;0.006875708083302461;0.8762458687964789;[NARS2]
GO:0002063;chondrocyte development;4.0;0.8933024483968273;0.6966512241984136;9.474373572664863;32.15320660831846;6.943860283624253;0.001076138889173156;0.6051093378270707;[EIF2AK3, RUNX2]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CIITA, ONECUT2, ELL, MAML1, GFI1, ARID4A, RORA, DDX41, HOXC13, AATF, IKZF2, ELK1, YY1, FLCN, NIPBL, DPF2, EP300, SOX8, IER5, ZNF564, IER2, ZNF485, KLF13, PEG3, NCOA6, ARNT, FLT3LG, SENP2, SAFB, TMEM173, PPRC1, MED6, RUNX2, SIRT2, CREB3, GAL, TFDP2, IL23A, RFX4, MTF2, TFEC, HOXB4, HDAC3, ZNF350, HDAC1, WBP2, MAX, RLF, SUPT6H, ARNTL, RXRA, HLTF, SCAP, NLRP3, E2F7, E2F8, TBX1, TFAP2A, ZNF462, DR1, CREBBP, NFYC, ATAD2, PBX3, ERLIN2, GRHL1, USF2, FLI1, SETX, CDK9, NFKBIA, TFCP2, COPS5, SP1, NFIB, NFIC, SP3, MAFF, BCL3, TAF7, CAMK1]
GO:0006543;glutamine catabolic process;10.0;0.8653626801206646;0.8479223519212526;9.5544162803384;559.4129836827092;8.67846133901236;0.018723049124860988;0.8590579283277371;[GLS]
GO:0045943;positive regulation of transcription by RNA polymerase I;11.0;0.8653626801206646;0.8651102923899945;9.54628615425515;1461.5699037633856;6.686031174322154;0.04891742935144542;0.7743528975167437;[EIF2AK3]
GO:0006537;glutamate biosynthetic process;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;829.4659717023219;8.16763571524637;0.027761479601967176;0.8329342821725234;[GLS]
GO:0106074;aminoacyl-tRNA metabolism involved in translational fidelity;9.0;1.0;0.896240625180289;9.628524252492122;129.69319001348046;7.212124270218933;0.004340714353458042;0.7650689957573628;[AARSD1]
GO:0070584;mitochondrion morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;64.70445744698846;6.781341354126479;0.002165599960519628;0.6370391240755715;[NDUFS6, NUBPL]
GO:0006419;alanyl-tRNA aminoacylation;11.0;0.8933024483968273;0.8790801765280758;9.5544162803384;205.4345073903719;8.67846133901236;0.006875708083302461;0.8762458687964789;[AARSD1]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[SFRP1, IGFBP5, TP53INP2, H3F3A, HSD17B4, SOX8, RRBP1, HSPE1, SND1, RUNX2]
GO:0042327;positive regulation of phosphorylation;8.0;0.5619039856592722;0.6559519928296361;8.01908634005802;180.92911571624816;2.8593680178451644;0.006055534677390216;0.5212282134068129;[VAC14, CDKN1A, HDAC3, NCF1, ITGB3, CIB1, LRP8, THBS1, STK3, FLCN, DVL3, NCKAP1L, ZNF622, ECT2, MARK2, TBX1, MAP3K3, FGA, FBXO18, KSR1, PDE6H, CCL20, SPHK1, FGG, GLMN, PLAUR, ZFP91, ARNT, FLT3LG, SENP2, GFRA2, ERN1, CDK9, CD4, KARS, ALS2, IL23A, JTB, CDK2AP1, CAMK1, ADNP, CALM1, EPHA1, CALM2, ARHGEF5, EZH2]
GO:1902187;negative regulation of viral release from host cell;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;120.0617835923913;7.069023426578259;0.004018359848247212;0.7365101867784198;[TRIM32]
GO:0051155;positive regulation of striated muscle cell differentiation;7.0;0.7586651285174919;0.7302519295159464;9.148951172230236;145.28799013580416;5.734022359845919;0.004862658279143298;0.64415753539903;[TBX1, IL4R, MAML1, FLT3LG, TRIM32]
GO:0006309;apoptotic DNA fragmentation;9.0;1.0;0.896240625180289;9.628524252492122;682.1166149099336;7.004484905440688;0.022829829235937554;0.7544503089863854;[FEN1, DFFA, KPNB1]
GO:0042692;muscle cell differentiation;4.0;0.6873818243518346;0.5936909121759173;8.242229891372231;21.066225782797595;5.382624473008031;7.050676185779127E-4;0.525267665867267;[MTPN, RXRA, IGFBP5, H3F3A, GLMN, RORA]
GO:0007080;mitotic metaphase plate congression;7.0;1.0;0.8509193652572005;9.628524252492122;61.63195576956532;6.193554689224359;0.002062766094448262;0.6676580400938822;[BECN1, SEH1L, NUP62, CDCA8, CHMP6, KPNB1]
GO:0016226;iron-sulfur cluster assembly;5.0;0.6696747006330769;0.6250783621774587;8.347590407030058;61.314195544967326;6.7325511899570465;0.0020521309456966027;0.6345439928109722;[NUBPL, FAM96B]
GO:1902230;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;831.2496569477559;6.409777797693995;0.02782117794191935;0.7430373465201421;[BID, TRIM32]
GO:0006361;transcription initiation from RNA polymerase I promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;6.311337724880743;0.015969835568764485;0.7190027299379095;[TBP, TAF1A, POLR1E, GTF2H4]
GO:0006360;transcription by RNA polymerase I;10.0;0.9326813400603323;0.8815816818910864;9.59462270081644;583.8786478812184;7.9853141584524145;0.01954189288791682;0.8236103492792612;[TAF1A]
GO:0006486;protein glycosylation;7.0;0.6181399273706679;0.6599893289425345;8.590536585640447;174.0766208890209;4.3090134865453384;0.005826187842367879;0.5712825153487487;[GALNT12, DPM3, COG3, FUT11, SYVN1, DOLK, MAN1B1, TRAK1, GALNT10]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[MAP3K3, CAD, EIF2AK3, CLK4, CLK3, CLK1, ERN1, BCR, FES, CAMK4, MKNK2, TRIM24, EPHA1, MARK2]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[ONECUT2, ELL, INTS10, ARID4A, HOXC13, ELK1, TRIM24, ZNF768, EP300, IER2, GTF2I, TBP, KLF13, ARNT, CREB3, TFDP2, RFX4, TFEC, LCOR, WBP2, MAX, RPAP1, SUPT6H, GTF2E2, ARNTL, POLR2B, TAF1A, HLTF, HIVEP1, POLR2G, TFAP2A, POLR2J3, NFYC, INTS3, PBX3, GRHL1, USF2, GTF2H4, FLI1, CDK9, GFI1B, TFCP2, COPS5, SP1, NFIB, NFIC, MAFF, NFE2L3, INTS4, TAF7]
GO:0006363;termination of RNA polymerase I transcription;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;6.343086423195323;0.015969835568764485;0.7206263598461826;[TBP, TAF1A, POLR1E, GTF2H4]
GO:1902235;regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway;9.0;0.8436909121759173;0.8180860812682478;9.517298617381897;141.89882988049482;6.280566066213989;0.004749226135444298;0.7174290658826632;[CREB3, SYVN1, EIF2AK3, SERINC3]
GO:0006364;rRNA processing;9.0;0.6347111282356054;0.7135961892980918;8.681142933547935;356.38664419027253;4.478756261132433;0.01192794025389202;0.6252844286580675;[RPS9, LAS1L, IMP4, BYSL]
GO:0045444;fat cell differentiation;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[BBS2, PER2, NIPBL, EP300, SOX8, OSBPL11, SENP2, TRIM32]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CREBBP, CDKN1A, TBP, MAML1, RORA, GTF2H4, MED6, RUNX2, GTF2E2, CDK9, RXRA, POLR2B, NPPA, TAF7, POLR2G, GTF2I]
GO:0006489;dolichyl diphosphate biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;346.04394917679554;8.16763571524637;0.011581779559612143;0.7686126355688037;[DOLK]
GO:0006368;transcription elongation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;5.459585514144159;0.015969835568764485;0.675444082270312;[CDK9, ELL, POLR2B, POLR2G, SUPT6H, GTF2H4]
GO:0018230;peptidyl-L-cysteine S-palmitoylation;10.0;1.0;0.9152410118609203;9.628524252492122;467.1984371929297;6.686031174322154;0.015636711241551894;0.7571649570480019;[ZDHHC23, ZDHHC24]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[NLRP12, DIABLO, EIF2AK3, NLRP3, NLRC4, BID, HSPE1, BBC3]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[RAD51C]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[HDAC3, DTX3L, BAG3, TPR, EIF2AK3, ECT2, TMEM173]
GO:0000707;meiotic DNA recombinase assembly;8.0;0.8259837884571596;0.7879918942285797;9.405380701177911;133.9647452985807;7.697632086000634;0.004483679464700174;0.7686572628545723;[RAD51C]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[IL23A, C1QBP, NCKAP1L]
GO:0006370;7-methylguanosine mRNA capping;10.0;1.0;0.9152410118609203;9.628524252492122;354.47150569988446;6.250713103064308;0.011863842292131473;0.734902770639515;[POLR2B, POLR2G, GTF2H4]
GO:0000027;ribosomal large subunit assembly;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;66.59596265062147;6.280566066213989;0.002228906937441061;0.6721078059595746;[RPL3, RPL23A, RPL3L]
GO:1990737;response to manganese-induced endoplasmic reticulum stress;7.0;1.0;0.8509193652572005;9.628524252492122;109.00578564445789;8.67846133901236;0.0036483255466820412;0.7947362817240173;[EIF2AK3]
GO:0015878;biotin transport;9.0;0.9326813400603323;0.8625812952104552;9.574457031221845;129.90173882037433;9.777073627680469;0.0043476942943430396;0.896240625180289;[SLC5A6]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[CLK1, ERN1, MAST3, CAMK4, STK38, MKNK2, EIF2AK3, STK38L, CAMK1, MARK2]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[CLK1, CSNK2A1, CAD, CAMK1, MARK2]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[CD151, ONECUT2, DOCK8, ITGB3, CIB1, THBS1, NIPBL, C1QBP, NCKAP1L, ATP7A, CLASP1, CCR2, SEMA6B, MAP3K3, IGFBP5, CCL20, ITGA2, SPHK1, PTP4A1, VIL1, CREB3, KARS, SP1, IL23A, RUFY3, EPHA1, TRIM32]
GO:1901165;positive regulation of trophoblast cell migration;8.0;1.0;0.875;9.628524252492122;361.5862730580211;7.9853141584524145;0.012101967152733394;0.7833693374183408;[C1QBP]
GO:0032076;negative regulation of deoxyribonuclease activity;8.0;0.7980440201809971;0.7740220100904985;9.464221201200845;815.0878885758623;9.083926447120524;0.027280258099159287;0.839552420951524;[DFFA]
GO:0043048;dolichyl monophosphate biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;243.37001040718545;9.777073627680469;0.008145375229539033;0.8509193652572005;[DOLK]
GO:0001570;vasculogenesis;4.0;0.8933024483968273;0.6966512241984136;9.292052015870908;21.066225782797595;5.6339389012889365;7.050676185779127E-4;0.5381198974168686;[SGPL1, GLMN, CCM2, RASIP1]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[OXTR, MAST3, MAML1, IL5RA, RASGRP4, STK3, NUAK1, ZMYM2, PABPN1, RPS6KA2, STK38, MKNK2, TRIM24, STK38L, NCAM1, MBP, MARK2, MAP3K3, CSNK2A1, KSR1, CAD, EIF2AK3, ERLIN2, CLK4, GFRA2, SPTB, GTF2H4, CLK3, SETX, CLK1, ERN1, CDK9, BCR, SNRK, ILF3, PAN3, KARS, PTPRA, FES, PDIK1L, CAMK4, FASTKD5, CCM2, CAMK1, CALM1, EPHA1]
GO:0000478;endonucleolytic cleavage involved in rRNA processing;9.0;0.7043150770688792;0.7483981637147287;9.01761517016915;464.47065400936236;7.069023426578259;0.015545414793243378;0.757750811958709;[LAS1L]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[CIITA, BTG2, GFI1, OTUD7B, IKZF2, YY1, FLCN, NIPBL, C1QBP, SAP130, WWC3, EP300, SOX8, LRRFIP1, ZNF564, DACT1, TLE4, KLF12, PEG3, SIRT2, EID1, MTF2, HOXB4, TIMELESS, LCOR, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, RXRA, BAG3, TPR, HIVEP1, SUDS3, E2F7, ZNF189, E2F8, IRX1, TFAP2A, DR1, CREBBP, UBE2I, PER2, GFI1B, CNOT1, NFIB, NFIC, PKIA, SP3, NFE2L3, TAF7, EZH2]
GO:0002534;cytokine production involved in inflammatory response;3.0;0.9326813400603323;0.6644609826203107;9.405380701177911;21.07076093796092;8.67846133901236;7.052194061398546E-4;0.6419372290569613;[SEH1L]
GO:0030449;regulation of complement activation;8.0;0.6873818243518346;0.7186909121759173;9.298282565621545;245.7676390307622;5.076593261888053;0.008225621701844479;0.6346172154986847;[CFH, C1QBP, A2M, C1QC, C2]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[ERRFI1, GAL, SP1, MAX, NPPA, CAD, SCAP, RAB8B]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[SETX, FBXO18, GINS4, ASCC3, CHD1, GTF2H4, MCM2]
GO:0032981;mitochondrial respiratory chain complex I assembly;7.0;1.0;0.8509193652572005;9.628524252492122;91.11357555959822;5.618190544320798;0.003049489377085438;0.638233890966345;[NDUFA7, NDUFB7, NDUFA11, NDUFB10, NDUFS7, NDUFS6, NUBPL, NDUFA10]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[NAB1, GFI1, ARID4A, IKZF2, ELK1, UBE2L3, YY1, SAP130, ZXDC, DPF2, TRIM24, EP300, ZNF326, SOX8, ZNF688, IER5, ZNF564, IER2, GTF2I, TLE4, ZNF441, CSNK2A1, ZNF282, SND1, ERN1, EID1, ILF3, ZNF93, RFX4, HOXB4, TIMELESS, ADNP, ZNF276, ZNF550, ZNF394, MAX, FOXG1, ZNF20, RPAP1, RLF, SUPT6H, GTF2E2, ZNF549, HLTF, HIVEP1, ZNF548, NLRP3, SUDS3, ZNF544, TRAPPC2, TFAP2A, ZNF264, DR1, ZNF260, INTS3, PBX3, CNOT10, FLI1, SOX30, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, SP1, SP3, ZNF30, MAFF, BCL3, ZNF658, NFE2L3, INTS4, CNOT8, TMEM18, ZNF532, ZNF410, EZH2, PHF3, SETD5, CIITA, BTG2, ONECUT2, ELL, INTS10, ATF7IP2, HOXC13, CHD1, NIPBL, ZMYM2, LBH, SCML1, C1QBP, NUP62, ZNF768, ZNF525, LRRFIP1, ZNF485, TSC22D4, KLF12, TBP, KLF13, BUD31, COMMD3, ARNT, BAZ1A, SAFB, PPRC1, ZFX, MED29, SIRT2, CREB3, ZNF519, TFDP2, TFEC, LCOR, VGLL4, ZNF630, ITGB3BP, HDAC3, ZNF350, HDAC1, WBP2, ZNF69, ARNTL, SERTAD3, POLR2B, TP53INP2, TP53INP1, TAF1A, POLR2G, GPBP1L1, ASCC3, E2F7, ZNF189, E2F8, TBX1, POLR2J3, ZNF462, EYA2, NFYC, ATAD2, GRHL1, USF2, GTF2H4, PER2, GFI1B, POLR3C, NFIB, NFIC, POLR3E, TAF7, MNDA, ZNF696]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[BECN1, ERRFI1, ABCC2, TFRC, CAD, ITPR2, EFTUD2, SETX, SFRP1, XRN1, TP53INP1, TIMELESS, ECT2, EZH2]
GO:0060734;regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation;9.0;1.0;0.896240625180289;9.628524252492122;361.7331880787673;9.777073627680469;0.012106884266262835;0.896240625180289;[EIF2AK3]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[CLIC5, OXTR, ABCC2, AMBP, IGFBP5, SPHK2, ITGA2, CAD, LNPEP, COMT, CRHR1, BYSL, NPPA]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[MAML1, GFI1, IKZF2, ELK1, UBE2L3, TIAL1, SAP130, ZXDC, DPF2, TRIM24, SOX8, FBXO5, IER5, IER2, CSNK2A1, ZNF282, FLT3LG, SND1, MED6, RUNX2, EID1, THAP6, SFRP1, KARS, IL23A, RFX4, BOLA3, HOXB4, TRIM14, ZNF276, ZNF394, FOXG1, ZNF20, HLTF, HIVEP1, SCAP, ZNF264, CREBBP, ZNF260, H3F3A, PBX3, EIF2AK3, ERLIN2, FLI1, SOX30, SETX, GOLGB1, PKIA, ZNF30, EZH2, CDKN1C, SETD5, AHCTF1, BTG2, CDKN1A, ELL, ATF7IP2, OTUD7B, HOXC13, AATF, NIPBL, ZMYM2, SCML1, C1QBP, ZNF485, TSC22D4, NCOA6, SPHK1, COMMD3, BAZ1A, TMEM173, PPRC1, ZFX, MED29, SIRT2, TOX4, GAL, MTF2, TFEC, VGLL4, ARHGEF5, ZNF350, NEDD8, TRAK1, ZNF69, ARNTL, SERTAD3, RXRA, UBN1, GPBP1L1, SCAND1, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, ITCH, NLRP12, CENPF, GFI1B, HIST3H2A, NFIB, NFIC, CAMK4, CAMK1, ZNF696, LIMS1, NCF1, NAB1, GMNN, ARID4A, CIB1, RORA, YY1, ADORA3, WWC3, EP300, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, TLE4, ZNF441, SSU72, ERN1, ILF3, ZNF93, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, STK3, BAG3, TPR, ZNF549, ZNF548, DVL3, NLRP3, SUDS3, ZNF544, TRAPPC2, TFAP2A, DR1, UBE2I, CNOT10, CDK9, NFKBIA, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT1, SP1, SP3, MAFF, BCL3, ZNF658, NFE2L3, CNOT8, ZNF532, ZNF410, USP36, CIITA, ONECUT2, ITGB2, DDX41, CHD1, FLCN, LBH, NUP62, GATAD1, ZNF768, ZNF525, LRRFIP1, DACT1, KLF12, TBP, KLF13, PEG3, DTX3L, BUD31, ZFP91, ARNT, SENP2, SAFB, CREB3, ZNF519, TFDP2, SETBP1, LCOR, ZNF630, ITGB3BP, MTPN, HDAC3, HDAC1, WBP2, NLRC4, LRP8, TP53INP2, TP53INP1, TAF1A, ASCC3, ZNF622, E2F7, ZNF189, E2F8, IRX1, TBX1, EYA2, FBXL15, USF2, CD4, POLR3C, TAF7, MNDA, TRIM32]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[MAML1, GFI1, ARID4A, RORA, IKZF2, ELK1, YY1, TIAL1, SAP130, ZXDC, DPF2, WWC3, EP300, SOX8, IER5, ZNF564, IER2, GTF2I, TLE4, ZNF441, ZNF282, SSU72, FLT3LG, MED6, RUNX2, EID1, THAP6, SFRP1, ZNF93, IL23A, RFX4, BOLA3, HOXB4, TIMELESS, ADNP, ZNF276, ZNF550, ZNF394, MAX, FOXG1, ZNF20, RLF, SUPT6H, BAG3, TPR, ZNF549, HLTF, HIVEP1, ZNF548, SCAP, NLRP3, SUDS3, ZNF544, TFAP2A, ZNF264, DR1, CREBBP, UBE2I, ZNF260, PBX3, ERLIN2, FLI1, SOX30, SETX, CDK9, NFKBIA, TFCP2, COPS5, CNOT1, SP1, PKIA, SP3, ZNF30, MAFF, BCL3, ZNF658, NFE2L3, ZNF532, ZNF410, EZH2, CIITA, AHCTF1, BTG2, CDKN1A, ONECUT2, ELL, OTUD7B, DDX41, HOXC13, AATF, CHD1, FLCN, NIPBL, ZMYM2, C1QBP, GATAD1, ZNF768, ZNF525, LRRFIP1, DACT1, ZNF485, TSC22D4, KLF12, TBP, KLF13, PEG3, NCOA6, BUD31, ZFP91, ARNT, SENP2, SAFB, TMEM173, PPRC1, ZFX, SIRT2, TOX4, CREB3, GAL, ZNF519, TFDP2, SETBP1, MTF2, TFEC, LCOR, HDAC3, ZNF350, HDAC1, WBP2, NEDD8, TRAK1, LRP8, ZNF69, ARNTL, RXRA, UBN1, ZNF622, E2F7, ZNF189, E2F8, IRX1, TBX1, ZNF462, NFYC, ATAD2, FBXL15, GRHL1, USF2, GTF2H4, PER2, GFI1B, NFIB, NFIC, TAF7, CAMK1, ZNF696]
GO:0006228;UTP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;8934.402720436805;7.474488534686424;0.29902641861260104;0.8146746435927894;[CAD]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[AVEN, BTG2, CDKN1A, DOCK8, CIB1, AATF, NUP62, CASP2, SOX8, TSC22D4, FGA, DFFA, FCER1G, CSNK2A1, SPHK2, SPHK1, FGG, PLAUR, FLT3LG, YWHAZ, DDB1, CREB3, SFRP1, CFDP1, PTRH2, VDAC2, ADNP, EPHA1, BECN1, HDAC3, HDAC1, NLRC4, THBS1, BAG3, LMNA, NCKAP1L, RFFL, SNCB, BID, NTSR1, TBX1, TFAP2A, UBE2B, EYA2, SYVN1, SETX, VIL1, NFKBIA, ITCH, SON, COPS5, BCL3, PDCD1, TRIM32, MAD2L1, CPEB4]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[HRK, DIABLO, NLRC4, THBS1, BBC3, STK3, ABR, FLCN, RPS6KA2, C1QBP, TP53INP1, CASP2, NLRP3, SUDS3, ZNF622, ECT2, BID, RBM5, NTSR1, TFAP2A, DFFA, FBXO18, ATPIF1, PLAUR, EIF2AK3, G0S2, HSPE1, YWHAZ, SIRT2, NLRP12, SFRP1, GAL, TFDP2, FAP, PTRH2, MNDA, PDCD1, SERINC3, ARHGEF5, ITGB3BP]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[SETX, BECN1, NCF1, TXNRD1, PRDX1, TP53INP1, PXMP2, GPX7, ECT2, SIRT2, EZH2]
GO:0032057;negative regulation of translational initiation in response to stress;10.0;0.8436909121759173;0.837086467948879;9.541512875502493;3170.177670468063;8.390779266560578;0.10610299365589344;0.8443458537639685;[EIF2AK3]
GO:0070417;cellular response to cold;5.0;0.8436909121759173;0.712086467948879;9.427853557029971;50.719091001651144;7.697632086000634;0.0016975223316068359;0.6838982747154925;[NFKBIA, EIF2AK3]
GO:0031642;negative regulation of myelination;7.0;1.0;0.8509193652572005;9.628524252492122;207.08553610705889;7.9853141584524145;0.006930966528620597;0.7592887026755414;[EIF2AK3]
